INVO Fertility, Inc. carries a market capitalization of 2.37M, placing it among publicly traded companies globally. Its enterprise value stands at 13.55M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.37M |
| Enterprise Value | 13.55M |
INVO Fertility, Inc. currently has 135,595.00 shares outstanding.
| Shares Outstanding | 135,595.00 |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
The price-to-sales ratio is 0.11, and the price-to-book ratio stands at -0.01.
| PE Ratio | N/A |
| PS Ratio | 0.11 |
| PB Ratio | -0.01 |
| P/TBV Ratio | -0.08 |
| P/FCF Ratio | -0.11 |
| P/OCF Ratio | -0.10 |
| EV / Sales | 1.95 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
INVO Fertility, Inc. maintains a current ratio of 0.12, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 72.39, indicating elevated leverage, while an interest coverage ratio of -9.21 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.12 |
| Quick Ratio | 0.07 |
| Debt / Equity | 72.39 |
| Debt / EBITDA | -0.51 |
| Interest Coverage | -9.21 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -161.54 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 19.50 |
| Income Tax | -54,008.00 |
| Effective Tax Rate | N/A |
INVO Fertility, Inc.'s stock has declined approximately -99.10338% over the past 52 weeks. The 50-day moving average sits at 2.05, while the 200-day moving average is 13.80.
| Beta (5Y) | N/A |
| 52-Week Price Change | -99.10338% |
| 50-Day Moving Average | 2.05 |
| 200-Day Moving Average | 13.80 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, INVO Fertility, Inc. generated 6.94M in revenue and converted that into -28.96M in net income, yielding earnings per share of -1,029.74. EBITDA reached -8.38M, while operating income came in at -9.15M.
| Revenue | 6.94M |
| Gross Profit | 2.72M |
| Operating Income | -9.15M |
| Pretax Income | -26.93M |
| Net Income | -28.96M |
| EBITDA | -8.38M |
| EBIT | -9.15M |
| Earnings Per Share (EPS) | -1,029.74 |
INVO Fertility, Inc. holds 355,891.00 in cash and equivalents against 4.23M in total debt, resulting in a net debt position of 1.63M. Total book value stands at -93.09M, with working capital of -8.11M providing operational flexibility.
| Cash & Cash Equivalents | 355,891.00 |
| Total Debt | 4.23M |
| Net Debt | 1.63M |
| Equity (Book Value) | -93.09M |
| Book Value Per Share | -3,566.12 |
| Working Capital | -8.11M |
INVO Fertility, Inc. produced -7.66M in operating cash flow over the past twelve months. After subtracting -110,463.00 in capital expenditures, free cash flow totaled -7.77M - equivalent to -297.56 per share.
| Operating Cash Flow | -7.66M |
| Capital Expenditures | -110,463.00 |
| Free Cash Flow | -7.77M |
| FCF Per Share | -297.56 |
INVO Fertility, Inc. operates with a gross margin of 39.17, reflecting its pricing power and cost economics. The operating margin of -131.84 and net profit margin of -417.01 provide insight into operational efficiency.
| Gross Margin | 39.17 |
| Operating Margin | -131.84 |
| Pretax Margin | -387.89 |
| Profit Margin | -417.01 |
| EBITDA Margin | -120.71 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -905.57 |
| FCF Yield | -950.96 |
INVO Fertility, Inc.'s most recent stock split took place on March 27, 2026 with a 5:1 split ratio.
| Last Split Date | 3/27/2026 |
| Split Ratio | 5:1 |
INVO Fertility, Inc. posts an Altman Z-Score of -14.14, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -14.14 |